The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis
Open Access
- 17 January 2024
- journal article
- research article
- Published by Springer Nature in Harm Reduction Journal
- Vol. 21 (1) , 1-11
Abstract
Background: Over the past decade in the USA, increases in overdose rates of cocaine and psychostimulants with opioids were highest among Black, compared to White, populations. Whether fentanyl has contributed to the rise in cocaine and psychostimulant overdoses in Ohio is unknown. We sought to measure the impact of fentanyl on cocaine and psychostimulant overdose death rates by race in Ohio. Methods: We conducted time series and spatiotemporal analyses using data from the Ohio Public Health Information Warehouse. Primary outcomes were state- and county-level overdose death rates from 2010 to 2020 for Black and White populations. Measures of interest were overdoses consisting of four drug involvement classes: (1) all cocaine overdoses, (2) cocaine overdoses not involving fentanyl, (3) all psychostimulant overdoses, and (4) psychostimulant overdoses not involving fentanyl. We fit a time series model of log standardized mortality ratios (SMRs) using a Bayesian generalized linear mixed model to estimate posterior median rate ratios (RR). We conducted a spatiotemporal analysis by modeling the SMR for each drug class at the county level to characterize county-level variation over time. Results: In 2020, the greatest overdose rates involved cocaine among Black (24.8 deaths/100,000 people) and psychostimulants among White (10.1 deaths/100,000 people) populations. Annual mortality rate ratios were highest for psychostimulant-involved overdoses among Black (aRR = 1.71; 95% CI (1.43, 2.02)) and White (aRR = 1.60, 95% CI (1.39, 1.80)) populations. For cocaine not involving fentanyl, annual mortality rate ratios were similar among Black (aRR = 1.04; 95% CI (0.96,1.16)) and White (aRR = 1.02; 95% CI (0.87, 1.20)) populations. Within each drug category, change over time was similar for both racial groups. The spatial models highlighted county-level variation for all drug categories. Conclusions: Without the involvement of fentanyl, cocaine overdoses remained constant while psychostimulant overdoses increased. Tailored harm reduction approaches, such as distribution of fentanyl test strips and the removal of punitive laws that influence decisions to contact emergency services, are the first steps to reduce cocaine overdose rates involving fentanyl among urban populations in Ohio. In parallel, harm reduction policies to address the increase in psychostimulant overdoses are warranted.Keywords
Funding Information
- National Institute on Drug Abuse (F31DA054752, R01DA052214, K01DA048174, R01DA052214, UH3DA044822, R01DA052214)
This publication has 51 references indexed in Scilit:
- County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Mortality, Causes of Death, and Health Status Among Methamphetamine UsersJournal of Addictive Diseases, 2014
- Side Effects of Cocaine Abuse: Multiorgan Toxicity and Pathological ConsequencesCurrent Medicinal Chemistry, 2012
- Contingency management: what it is and why psychiatrists should want to use itThe Psychiatrist, 2011
- Substance Abuse Stigma and Discrimination Among African American Male Substance UsersStigma Research and Action, 2011
- Heterogeneity of Stimulant Dependence: A National Drug Abuse Treatment Clinical Trials Network StudyThe American Journal on Addictions, 2009
- Need-service matching in substance abuse treatment: Racial/ethnic differencesEvaluation and Program Planning, 2009
- Methamphetamine and cardiovascular pathology: a review of the evidenceAddiction, 2007
- Barriers and Pathways to Diffusion of Methamphetamine Use Among African Americans in the Rural SouthJournal of Ethnicity in Substance Abuse, 2005
- Ethnic Disparities in Unmet Need for Alcoholism, Drug Abuse, and Mental Health CareAmerican Journal of Psychiatry, 2001